| A Phase 2 Trial of Rebamipide Liquid to Determine the Effective Dose for Prevention of Chemoradiotherapy-induced Oral Mucositis in Patients With Head and Neck Cancer (NCT02085460) | Otsuka Pharmaceutical Co., Ltd. | 2014-03-01 |
| Prognostic Markers for a Better Follow-up in Head and Neck Cancer. (NCT06094985) | Karolinska Institutet | 2014-02-12 |
| Progressive Resistance Training Program in Head and Neck Cancer Patients (NCT02068950) | Herlev Hospital | 2014-02-01 |
| Clinical Registry of Long-Term Dental Outcomes in Head and Neck Cancer Patients (NCT05325970) | Wake Forest University Health Sciences | 2014-02-01 |
| Photodynamic Therapy With LUZ11 in Advanced Head and Neck Cancer (NCT02070432) | Luzitin SA | 2014-02-01 |
| Observational Study of Dental Outcomes in Head and Neck Cancer Patients (NCT02057510) | Wake Forest University Health Sciences | 2014-02-01 |
| Sensor-Assisted Prevention of Dehydration in Head and Neck Cancer Patients (NCT02253238) | M.D. Anderson Cancer Center | 2014-01-07 |
| NBTXR3 and Radiation Therapy in Treating Patients With Locally Advanced SCC of the Oral Cavity or Oropharynx (NCT01946867) | Nanobiotix | 2014-01-03 |
| Predictive Modelling for Patient Stratification According to Treatment-related Toxicity and Survival After Chemoradiation for Head and Neck Cancer (NCT02103010) | University Hospital, Ghent | 2014-01-01 |
| Ensuring Communication in Hospice by Oncology Study (ECHO) (NCT02069769) | Massachusetts General Hospital | 2014-01-01 |
| Study of Chemotherapy With Cisplatin/Carboplatin, and Docetaxel With or Without Erlotinib in Patients With Head and Neck Squamous Cell Carcinomas Amenable for Surgical Resection (NCT01927744) | M.D. Anderson Cancer Center | 2013-12-16 |
| ADXS 11-001 Vaccination Prior to Robotic Surgery, HPV-Positive Oropharyngeal Cancer (NCT02002182) | Andrew Sikora | 2013-12-01 |
| BNCT and IG-IMRT for Recurrent Head and Neck Cancer (NCT02004795) | Taipei Veterans General Hospital, Taiwan | 2013-11-01 |
| LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab (NCT01986426) | Lytix Biopharma AS | 2013-11-01 |
| Study Comparing Radiation Therapy and Chemotherapy With or Without Nimotuzumab (NCT01345084) | Eurofarma Laboratorios S.A. | 2013-11-01 |
| Investigation of the Role of Human Papilloma Virus (HPV) in the Prognosis of Head and Neck Cancer (NCT02049177) | University of Aberdeen | 2013-11-01 |
| Post-operative Radiation With Cetuximab for Locally Advanced Cutaneous Squamous Cell Carcinoma of the Head and Neck (NCT01979211) | University of Cincinnati | 2013-10-01 |
| Comparison of Tumor Glucose Metabolism Before and After Artificial Nutrition (NCT02382237) | Institut du Cancer de Montpellier - Val d'Aurelle | 2013-10-01 |
| A Study of MEHD7945A in Combination With Cisplatin and 5-Fluorouracil (5-FU) or Paclitaxel and Carboplatin in Participants With Recurrent/Metastatic Squamous Cell Carcinoma of the Head and Neck (R/M SCCHN) (NCT01911598) | Genentech, Inc. | 2013-09-19 |
| Ferumoxytol - Iron Oxide Nanoparticle Magnetic Resonance Dynamic Contrast Enhanced MRI (NCT01895829) | M.D. Anderson Cancer Center | 2013-09-12 |
| Predictive Models for Radiation-induced Side Effects in Head and Neck Cancer Based on Single Nucleotide Polymorphisms (SNP) (NCT02489084) | University Medical Center Groningen | 2013-09-01 |
| Validity and Reliability of Outcome Measures in Patients With Cancer of the Head and Neck (NCT01952821) | Mayo Clinic | 2013-09-01 |
| The Impact of a Patient Education Intervention for Ambulatory Oncology Patients (NCT02038114) | Sunnybrook Health Sciences Centre | 2013-09-01 |
| Parotid-gland Stem-cell Sparing Intensity-modulated Radiotherapy (NCT01955239) | University Medical Center Groningen | 2013-09-01 |
| Concurrent Chemotherapy Based on Genetic Testing in Patients With High-Risk Salivary Gland Tumors (NCT02921984) | Shanghai Ninth People's Hospital Affiliated to Shanghai Jiao Tong University | 2013-09-01 |
| Use of the Passy Muir Swallowing Self Trainer (NCT02848664) | James Madison University | 2013-08-01 |
| Skin Rash Study Before Chemotherapy in Colorectal & Head and Neck Cancer Patients (NCT01874860) | University of Louisville | 2013-08-01 |
| Physical Exercise for Patients Who Suffer From Weight Loss Due to Head and Neck Cancer Undergoing Medical Treatment (NCT03524755) | Ludwig-Maximilians - University of Munich | 2013-07-10 |
| Dynamic Contrast Enhanced Computed Tomography (CT) for Head and Neck Cancer (NCT01549379) | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2013-07-01 |
| Study of Personalized Sterile Humidification Device for Mucositis in Head and Neck Cancer Patients (NCT01930435) | University of California, San Francisco | 2013-07-01 |
| Topical/Oral Melatonin for Preventing Concurrent Radiochemotherapy Induced Oral Mucositis/Xerostomia Cancer Patients (NCT02430298) | Khon Kaen University | 2013-07-01 |
| Quantitative Endoscopy of H&N (NCT02704169) | University Health Network, Toronto | 2013-07-01 |
| Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma (NCT01794845) | University of Miami | 2013-06-03 |
| Phase II Study of Cetuximab With or Without OSI-906 in Head and Neck Squamous Cell Carcinoma (HNSCC) (NCT01427205) | M.D. Anderson Cancer Center | 2013-06-01 |
| Testing Accountability in Patient Adherence (NCT01844557) | M.D. Anderson Cancer Center | 2013-05-01 |
| Radiation and Cetuximab Plus Intratumoral EGFR Antisense DNA in Locally Advanced Head and Neck Squamous Cell Carcinoma (NCT01592721) | The University of Texas Health Science Center at San Antonio | 2013-04-01 |
| Therapeutic Education Program for Laryngectomised Patients and Their Close Relations (NCT02903875) | University Hospital, Caen | 2013-04-01 |
| Prediction of Outcome After Chemoradiotherapy for Head and Neck Cancer Using Functional Imaging and Tumor Biology (NCT01829646) | Universitaire Ziekenhuizen KU Leuven | 2013-03-01 |
| Couple-Based Intervention for Patients With Head and Neck Cancer and Their Partners (NCT01785576) | Endeavor Health | 2013-03-01 |
| Symptom Burden in Head and Neck Cancer (NCT01219673) | M.D. Anderson Cancer Center | 2013-03-01 |
| Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma (NCT01827709) | Universitaire Ziekenhuizen KU Leuven | 2013-03-01 |
| Prognostic Value of Pre-therapy 18F-FDG PET/CT for the Outcome of 18 FDG PET-guided SIB-IMRT in Patients With Head and Neck Cancer (NCT06171464) | IRCCS San Raffaele | 2013-02-21 |
| Intranasal Transmucosal Fentanyl Pectin for Breakthrough Cancer Pain in Radiation-induced Oropharyngeal Mucositis (NCT02050503) | Grupo de Investigación Clínica en Oncología Radioterapia | 2012-12-01 |
| Trial of Acupuncture for Radiation-Induced Xerostomia in Head and Neck Cancer (NCT02589938) | Wake Forest University Health Sciences | 2012-11-11 |
| Induction Chemotherapy With Afatinib, Ribavirin, and Weekly Carboplatin/Paclitaxel for Stage IVA/IVB HPV Associated Oropharynx Squamous Cell Cancer (OPSCC) (NCT01721525) | Memorial Sloan Kettering Cancer Center | 2012-11-01 |
| Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation Therapy (NCT00928161) | M.D. Anderson Cancer Center | 2012-11-01 |
| Neuropathic Pain in Head and Neck Cancer (NCT01846286) | M.D. Anderson Cancer Center | 2012-10-15 |
| Alcohol and Tobacco Consumption in Patients With Head and Neck Cancer : Interest of an Addiction Support (NCT01652456) | Centre Oscar Lambret | 2012-10-01 |
| Complete Decongestive Therapy (CDT) for Treatment of Head and Neck Lymphedema (NCT00951470) | M.D. Anderson Cancer Center | 2012-10-01 |
| Free Flaps : Should we Propose Them to the Elderly ? (NCT03346928) | Hospices Civils de Lyon | 2012-10-01 |
| Induction Chemotherapy Followed by Chemoradiotherapy for Head and Neck Cancer (NCT01716195) | University of California, Davis | 2012-10-01 |
| A Pilot Study of ALTENS in Improving Dysphagia Induced by IMRT for Head and Neck Cancers (NCT01697891) | McMaster University | 2012-10-01 |
| Adaptive Radiation Treatment for Head and Neck Cancer (NCT01504815) | The Netherlands Cancer Institute | 2012-09-07 |
| A Study of [F-18]HX4 (PET Imaging)Evaluated in Head and Neck Cancer Patients (NCT01506427) | Siemens Molecular Imaging | 2012-09-01 |
| A Prospective Observational Study to Evaluate Acute Kidney Injury Biomarkers In Patients Receiving First Cycle of Cisplatin Chemotherapy for Head and Neck Cancers (NCT01936376) | Foundation for the National Institutes of Health | 2012-09-01 |
| Edible Plant Exosome Ability to Prevent Oral Mucositis Associated With Chemoradiation Treatment of Head and Neck Cancer (NCT01668849) | University of Louisville | 2012-08-02 |
| Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy (NCT01709006) | Centre hospitalier de l'Université de Montréal (CHUM) | 2012-08-01 |
| Feasibility Study of Dynasplint to Prevent Trismus in Head and Neck Cancer (NCT01649583) | Vanderbilt University Medical Center | 2012-08-01 |
| Effect of the Rehabilitation Effort at Home in Patients With Head and Neck Tumor Treated With Curative Intent (NCT02135185) | Institut du Cancer de Montpellier - Val d'Aurelle | 2012-07-01 |
| Outcome Prediction in Head&Neck Cancer Patients After Radiotherapy (NCT01985984) | Maastricht Radiation Oncology | 2012-07-01 |
| Finding Predictors of Side Effects to Chemoradiation Treatment in Elderly Patients With Head and Neck Cancer (NCT01688323) | UNC Lineberger Comprehensive Cancer Center | 2012-07-01 |
| A Study of MEHD7945A Versus Cetuximab in Patients With Recurrent/Metastatic Squamous Cell Carcinoma of The Head And Neck (NCT01577173) | Genentech, Inc. | 2012-07-01 |
| Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer (NCT01581970) | Masonic Cancer Center, University of Minnesota | 2012-06-01 |
| Studying Biomarkers in Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on E1302 Trial (NCT01619618) | Eastern Cooperative Oncology Group | 2012-06-01 |
| Multimodality Risk Adapted Tx Including Induction Chemo for SCCHN Amenable to Transoral Surgery (NCT01612351) | UNC Lineberger Comprehensive Cancer Center | 2012-06-01 |
| Intra-arterial Versus Intravenous Cisplatin, Combined With Radiation, for Oral Cavity and Oropharynx Cancer (NCT01587820) | Southern Illinois University | 2012-06-01 |
| A Dose Finding Study of Eribulin Mesylate and Cetuximab For Patients With Advanced Head and Neck and Colon Cancer (NCT01744340) | howard safran | 2012-05-01 |
| Irradiation Modulates the Pharmacokinetics of Anticancer Drugs for Head and Neck Cancer (NCT01609114) | Far Eastern Memorial Hospital | 2012-04-01 |
| CD2 Lozenges in Preventing Acute Oral Mucositis in Patients With Head and Neck Cancer Receiving Radiotherapy and Chemotherapy (NCT01545687) | Alliance for Clinical Trials in Oncology | 2012-04-01 |
| Effect of Omega-3 Supplements on the Prevention of Cachexia in Head and Neck Cancer Treated With Radio(Chemo)Therapy (NCT01596933) | General Hospital Groeninge | 2012-04-01 |
| Safety Study of HPV DNA Vaccine to Treat Head and Neck Cancer Patients (NCT01493154) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2012-04-01 |
| Alcohol and Tobacco Consumption in Patients With Head and Neck or Lung Cancer (NCT01647425) | Centre Oscar Lambret | 2012-04-01 |
| Positron Emission Tomography/Magnetic Resonance Imaging in Patients (NCT01557881) | Case Comprehensive Cancer Center | 2012-02-01 |
| Application of High Resolution Diffusion-weighted MR Imaging Pulse Sequence in Head and Neck, and Prostate Cancers (NCT01535898) | Memorial Sloan Kettering Cancer Center | 2012-02-01 |
| MLN8237 in Head and Neck Cancer (NCT01540682) | Abramson Cancer Center at Penn Medicine | 2012-02-01 |
| Impact of Applying a Bandage Skin Hydrogel on the Pains of the Head and Neck in Patients With Cancer of Head and Neck Treated With Radiotherapy (NCT01520701) | Centre Francois Baclesse | 2012-02-01 |
| Induction Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck (NCT01412229) | UNC Lineberger Comprehensive Cancer Center | 2012-02-01 |
| A New Oral salIvary equivAlent Compared to Two moisturizinG Mouth sprAys in Patients With xeRostomiA: NIAGARA Study (NCT02049112) | Unither Pharmaceuticals, France | 2012-01-01 |
| Biomarkers in Tissue Samples From Patients With Recurrent or Metastatic Head and Neck Cancer Treated on ECOG-E1395 and ECOG-E3301 (NCT01487733) | Eastern Cooperative Oncology Group | 2011-12-22 |
| Controlled Trial Of Acupuncture To Prevent Radiation-Induced Xerostomia (NCT01266044) | M.D. Anderson Cancer Center | 2011-12-09 |
| Torisel in Addition to Standard Chemotherapy With Radiation for Advanced Head and Neck Cancer (NCT01326468) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-12-08 |
| Feasibility Study to Estimate Number of Patients With Precancerous Areas in Their Airways and the Response to Gefitinib (NCT01405846) | Papworth Hospital NHS Foundation Trust | 2011-12-01 |
| Optical Imaging of Head and Neck Cancer (NCT01456143) | Sharmila Anandasabapathy, MD | 2011-12-01 |
| Efficacy of Prophylactic Treatment With Antibiotics During Concomitant Chemoradiotherapy in Patients With Head and Neck Cancer to Prevent Aspiration Pneumonia (NCT01598402) | Radboud University Medical Center | 2011-12-01 |
| Neoviderm Skin Emulsion in the Prevention of Radiation Dermatitis (NCT01701466) | Sir Mortimer B. Davis - Jewish General Hospital | 2011-12-01 |
| Selective IMRT for Locally Advanced Head and Neck Carcinoma With Concurrent Panitumumab (NCT01312493) | UNC Lineberger Comprehensive Cancer Center | 2011-12-01 |
| Treatment Selection According to Skin Reaction to Cetuximab (NCT01472653) | Institute of Oncology Ljubljana | 2011-12-01 |
| Biomarkers in Patients With Head and Neck Cancer (NCT01466257) | ECOG-ACRIN Cancer Research Group | 2011-11-21 |
| Biomarkers in Patients With Metastatic or Recurrent Head and Neck Cancer Treated With Cisplatin and Cetuximab on ECOG-E5397 (NCT01466244) | Eastern Cooperative Oncology Group | 2011-11-11 |
| Phase I Study of CUDC-101 With Cisplatin and Radiation in Subjects With Head & Neck Cancer (NCT01384799) | Curis, Inc. | 2011-11-01 |
| Percutaneous Endoscopic Gastrostomy in Hands of ORL-HN Surgeon (NCT02937610) | University of Helsinki | 2011-10-01 |
| DAHANCA 25B: Progressive Resistance Training as Intervention for Regaining Muscle Mass After Radiation Therapy in Patients With HNSCC (NCT01509430) | Danish Head and Neck Cancer Group | 2011-10-01 |
| Magnetic Resonance Imaging (MRI) in the Assessment of Head and Neck Squamous Cell Carcinoma (HNSCC) Response (NCT00994201) | OHSU Knight Cancer Institute | 2011-10-01 |
| Docetaxel, Cisplatin, and Cetuximab (TPC) in Palliative Treatment of Patients With Squamous Cell Carcinoma of the Head and Neck (SCCHN) (NCT01437449) | Stanford University | 2011-10-01 |
| MRI for Eval Tumor & Node Response & Normal Tissue Function to Concurrent Chemo & Radiation Therapy in H&N Cancer (GCC1043) (NCT01768442) | University of Maryland, Baltimore | 2011-09-01 |
| Mirror Grant - Toward an Understanding of Body Image Adaptation Following Surgical Treatment for Head and Neck Cancer (NCT01432132) | M.D. Anderson Cancer Center | 2011-08-24 |
| Feasibility of IMRT Modulation to Account for Scattered Radiation From Dental Fillings in Head and Neck Cancer (NCT01576939) | Stanford University | 2011-08-01 |
| Safety Study of MGA271 in Refractory Cancer (NCT01391143) | MacroGenics | 2011-07-01 |
| MRI and PET-CT for Radiotherapy Planning for Head and Neck Cancer (NCT02273778) | The Leeds Teaching Hospitals NHS Trust | 2011-06-01 |
| Skin Changes in Head and Neck Cancer During Immuno-(Chemo-) And Radiotherapy With Erbitux® (HICARE) (NCT01553032) | University of Heidelberg Medical Center | 2011-06-01 |